Current Pharmaceutical Design
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.2 | Q2 | 56.5% | 0.632 | Q2 | 69.4% |
| 2024 | 2.8 | Q2 | 55.8% | 0.611 | Q2 | 69.0% |
| 2023 | 2.6 | Q2 | 52.4% | 0.586 | Q2 | 70.2% |
| 2022 | 3.1 | Q3 | 55.0% | 0.580 | Q2 | 71.0% |
| 2021 | 3.3 | Q3 | 56.4% | 0.571 | Q2 | 71.3% |
| 2020 | — | — | 0.690 | Q2 | 75.8% | |
| 2019 | — | — | 0.606 | Q2 | 72.9% | |
| 2018 | — | — | 0.703 | Q2 | 75.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-4286
ISSN
1381-6128
region
Middle East
coverage
1995-2026